Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy
- 1 November 2000
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 30 (2) , 127-134
- https://doi.org/10.1016/s0169-5002(00)00131-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patientsAnnals of Oncology, 1997
- Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centresBritish Journal of Cancer, 1996
- Tumour markers for prediction of survival and monitoring of remission in small cell lung cancerBritish Journal of Cancer, 1993
- Extensive small-cell lung cancer. A randomized comparison of two chemotheraphy programs with early crossover in instances of failureAnnals of Oncology, 1992
- Small-cell carcinoma of the lung: derivation of a prognostic staging system.Journal of Clinical Oncology, 1991
- Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.Journal of Clinical Oncology, 1990
- Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?British Journal of Cancer, 1990
- An overview of prognostic factors in small cell lung cancerBritish Journal of Cancer, 1990
- The prognostic influence of serum neuron specific enolase in small cell lung cancerBritish Journal of Cancer, 1988
- Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patientsInternational Journal of Cancer, 1987